Cooperation between integrin α5 and tetraspan TM4SF5 regulates VEGF-mediated angiogenic activity

Blood

Volumn 113, Issue 8, 2009, Pages 1845-1855

  Choi, Suyong ^a,b   Lee, Sin Ae ^a,b   Kwak, Tae Kyoung ^a,b   Kim, Hyeon Jung ^a   Lee, Mi Ji ^a,b   Ye, Sang Kyu ^b   Kim, Sung Hoon ^c   Kim, Semi ^d   Lee, Jung Weon ^a,b,e  

^a Stem Cell Research Center   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Kyung Hee University   (South Korea)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^e Metropolitan Government Seoul National University Boramae Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; STAT3 PROTEIN; TETRASPANIN; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; ANTIBODY; FOCAL ADHESION KINASE; MEMBRANE PROTEIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE C SRC; PROTEIN-TYROSINE KINASE C-SRC; STAT3 PROTEIN, HUMAN; TM4SF5 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; UMBILICAL VEIN; ANIMAL; AORTA; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CULTURE MEDIUM; CYTOLOGY; EPITHELIUM CELL; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; LIVER TUMOR; MALE; METABOLISM; NUDE MOUSE; PHYSIOLOGY; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; ANTIBODIES; AORTA; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; EPITHELIAL CELLS; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; INTEGRIN ALPHA5; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 61849092563     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-05-160671     Document Type: Article

References (34)

1. Folkman J. Angiogenesis in cancer, vasculature, rhumatoid and other diseases. Nat Med. 1995;1: 27-31.
2. Stupack DG, Cheresh DA. Integrins and angio-genesis. Curr Top Dev Biol. 2004;64:207-238.
3. Weis SM. Evaluating integrin function in models of angiogenesis and vascular permeability. Methods Enzymol. 2007;426:505-528.
4. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57-70.
5. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669-676.
6. Giordano FJ, Johnson RS. Angiogenesis: the role of the microenvironment in flipping the switch. Curr Opin Genet Dev. 2001;11:35-40.
7. Park SI, Shah AN, Zhang J, Gallick GE. Regulation of angiogenesis and vascular permeability by Src family kinases: opportunities for therapeutic treatment of solid tumors. Expert Opin Ther Targets. 2007;11:1207-1217.
8. Mitra SK, Schlaepfer DD. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol. 2006;18:516-523.
9. Hemler ME. Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol. 2005;6: 801-811.
10. Brakebusch C, Fassler R. The integrin-actin connection, an eternal love affair. EMBO J. 2003;22: 2324-2333.
11. Juliano RL, Reddig P, Alahari S, Edin M, Howe A, Aplin A. Integrin regulation of cell signalling and motility. Biochem Soc Trans. 2004;32:443-446.
12. Carragher NO, Westhoff MA, Fincham VJ, Schaller MD, Frame MC. A novel role for FAK as a protease-targeting adaptor protein: regulation by p42 ERK and Src Curr Biol. 2003;13:1442-1450.
13. Lee JW, Juliano R. Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathways. Mol Cells. 2004;17:188-202.
14. Carragher NO, Frame MC. Focal adhesion and actin dynamics: a place where kinases and proteases meet to promote invasion. Trends Cell Biol. 2004;14:241-249.
15. Seaman S, Stevens J, Yang MY, Logsdon D, Graff-Cherry C, St Croix B. Genes that distinguish physiological and pathological angiogenesis. Cancer Cell. 2007;11:539-554.
16. Eliceiri BP. Integrin and growth factor receptor crosstalk. Circ Res. 2001;89:1104-1110.
17. Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol. 2004; 5:816-826.
18. Charrin S, Manie S, Billard M, et al. Multiple levels of interactions within the tetraspanin web. Biochem Biophys Res Commun. 2003;304:107-112.
19. Stipp CS, Kolesnikova TV, Hemler ME. Functional domains in tetraspanin proteins. Trends Biochem Sci. 2003;28:106-112.
20. Berditchevski F. Complexes of tetraspanins with integrins: more than meets the eye. J Cell Sci. 2001;114:4143-4151.
21. Yang X, Kovalenko OV, Tang W, Claas C, Stipp CS, Hemler ME. Palmitoylation supports assembly and function of integrin-tetraspanin complexes. J Cell Biol. 2004;167:1231-1240.
22. Wright MD, Ni J, Rudy GB. The L6 membrane proteins: a new four-transmembrane superfamily. Protein Sci. 2000;9:1594-1600.
23. Muller-Pillasch F, Wallrapp C, Lacher U, et al. Identification of a new tumour-associated antigen TM4SF5 and its expression in human cancer. Gene. 1998;208:25-30.
24. Lee SA, Lee SY, Cho IH, et al. Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelial-mesenchymal transition in human hepatocarcinoma. J Clin Invest. 2008;118: 1354-1366.
25. Lee SY, Kim TY, Lee MS, et al. Focal adhesion and actin organization by a cross-talk ofTM4SF5 with integrin α2 are regulated by serum treatment. Exp Cell Res. 2006;312:2983-2999.
26. Lee JW, Juliano RL. α5β1 integrin protects intestinal epithelial cells from apoptosis through a phosphatidylinositol 3-kinase and protein kinase B-dependent pathway. Mol Biol Cell. 2000;11: 1973-1987.
27. Kim HP, Lee MS, Yu J, et al. TGF-β1 (transforming growth factor-β1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity. Biochem J. 2004;379:141-150.
28. Jung JE, Lee HG, Cho IH, et al. STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. FASEB J. 2005;19:1296-1298.
29. Choi S, Oh SR, Lee SA, et al. Regulation of TM4SF5-mediated tumorigenesis through induction of cell detachment and death by tiarellic acid. Biochim Biophys Acta. 2008;1783:1632-1641.
30. Kassner PD, Alon R, Springer TA, Hemler ME. Specialized functional properties of the integrin α4 cytoplasmic domain. Mol Biol Cell. 1995;6: 661-674.
31. Lekishvili T, Fromm E, Mujoomdar M, Berditchevski F. The tumour-associated antigen L6 (L6-Ag) is recruited to the tetraspanin-en-riched microdomains: implication for tumour cell motility. J Cell Sci. 2008;121:685-694.
32. Parsons JT. Focal adhesion kinase: the first ten years. J Cell Sci. 2003;116:1409-1416.
33. Wu L, Bernard-Trifilo JA, Lim Y, et al. Distinct FAK-Src activation events promote α5β1 and α4β1 integrin-stimulated neuroblastoma cell motility. Oncogene. 2008;27:1439-1448.
34. Pascual-Le Tallec L, Dulmet E, Bertagna X, de Keyzer Y. Identification of genes associated with the corticotroph phenotype in bronchial carcinoid tumors. J Clin Endocrinol Metab. 2002;87:5015-5022.